Description

3β-[(6-Deoxy-4-o-β-D-Glucopyranosyl-3-o-Methyl-β-D-Galactopyranosyl)Oxy]-14-Oxo-8,15-Cyclo-14,15-Seco-5β-Card-20(22)-Enolide is a high-purity, structurally complex cardiac glycoside derivative, valued for its role as a critical reference standard and advanced pharmaceutical intermediate in research and development. Its precise molecular architecture makes it essential for analytical method development, bioactivity studies, and the synthesis of novel therapeutic agents. This compound is primarily sought by pharmaceutical R&D laboratories, analytical service providers, and manufacturers of fine chemicals and active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Reference Standard: Used for the qualitative and quantitative analysis (HPLC, LC-MS) of cardiac glycosides in drug substances and finished products.
• Biochemical Research: Serves as a key intermediate or probe in studying the structure-activity relationships (SAR) and mechanism of action of cardiotonic steroids.
• API Synthesis: Acts as a sophisticated building block in the multi-step synthesis of novel cardiac drugs and specialized therapeutic agents.
• Quality Control Laboratories: Employed as a certified standard to ensure the purity, potency, and identity of related compounds in manufacturing processes.
• Academic Research: Utilized in university and institutional labs for pharmacological studies targeting sodium-potassium ATPase inhibition.
• Metabolite Identification: Aids in the identification and characterization of metabolic pathways and breakdown products of related cardiac drugs.

Basic Information

Item	Details
Product Name	3β-[(6-Deoxy-4-o-β-D-Glucopyranosyl-3-o-Methyl-β-D-Galactopyranosyl)Oxy]-14-Oxo-8,15-Cyclo-14,15-Seco-5β-Card-20(22)-Enolide
CAS No.	71659-74-0
Molecular Formula	C36H52O13
Molecular Weight	692.79 g/mol
Synonyms	14-Oxo-8,15-cyclo-14,15-seco-5β-card-20(22)-enolide, 3-[(6-deoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-galactopyranosyl)oxy]-; 8,15-Cyclo-14,15-secocard-20(22)-enolide derivative; Cardiac glycoside aglycone derivative; 3β-[(6-Deoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-galactopyranosyl)oxy]-14-oxo-8,15-cyclo-14,15-seco-5β-card-20(22)-enolide; 71659-74-0; 14-Oxo-8,15-cyclo-14,15-seco-5β-card-20(22)-enolide 3-[(6-deoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-galactopyranosyl)oxy]-
EINECS	Contact for details

Quality Control

Our 3β-[(6-Deoxy-4-o-β-D-Glucopyranosyl-3-o-Methyl-β-D-Galactopyranosyl)Oxy]-14-Oxo-8,15-Cyclo-14,15-Seco-5β-Card-20(22)-Enolide is manufactured under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC for purity, spectroscopic identification (IR, NMR), and residual solvent analysis, to ensure it meets the exacting standards required for research and development. A detailed Certificate of Analysis (COA) is provided with every shipment, confirming identity, purity, and conformance to specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccant use and inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Residual Solvents (GC)	Complies with ICH guidelines
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.